Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1 Clinical Trial to Determine the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous GH002 in Healthy Volunteers

Next Previous
Trial Profile

A Phase 1 Clinical Trial to Determine the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous GH002 in Healthy Volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 25 May 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs 5 Methoxy N N Dimethyltryptamine (Primary)
  • Indications Bipolar disorders; Major depressive disorder
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Acronyms GH002-HV-105
  • Sponsors GH Research

Most Recent Events

  • 15 May 2025 According to a GH Research media release, company announces acceptance of posters have been accepted presenting safety and tolerability data at the International Society for Bipolar Disorders (ISBD) Annual Conference in Chiba, Japan from September 17 -19.
  • 02 May 2024 According to a GH Research media release, the analyses of the PK/PD relationship, and various other secondary endpoints, are ongoing and will inform the further clinical development strategy for GH002.
  • 24 Jan 2024 Status changed from recruiting to completed.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top